PHARMACY PRACTICE
15. The Committee recommends RETAINING the following policy statement as written.
2005 Compounding with Multicomponent Vehicles
1. APhA encourages companies that offer multi-component vehicles for compounding to list all
ingredients and to restrict claims about the vehicles to the structure and function of the ingredients in
those vehicles unless clinical evidence exists to support more specific claims.
2. When claims are made by companies for systemic delivery of active ingredients in multicomponent
vehicles, APhA encourages pharmacists to secure bioavailability data in support of such
claims.
(JAPhA NS45(5):555 September/October 2005)(Reviewed 2009)
SOURCE FOUND HERE
No comments:
Post a Comment